Alzheimers Drug Discovery Foundation
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2020 | 27,631,350 | 28,251,909 | −620,559 | 20.9 | 7% |
| 2021 | 53,037,104 | 37,126,176 | 15,910,928 | 20.7 | 9% |
| 2022 | 254,027,105 | 36,842,901 | 217,184,204 | 92.3 | 9% |
| 2023 | 37,742,020 | 61,943,588 | −24,201,568 | 50.4 | 10% |
In its most recent public year (2023), this organization spent $24,201,568 more than it brought in. Its reserves stood at about 50.4 months of spending, up from 20.9 in 2020. Staff pay was 10% of spending. $185,412,696 of its net assets are donor-restricted.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works